Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ventricular Tachycardia Antiarrhythmics or AblatioN In Structural Heart Disease 2

NCT02830360 is registered in ClinicalTrials.gov with John Sapp as lead sponsor.

NCT NCT02830360
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02830360 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ventricular Tachycardia Antiarrhythmics or AblatioN In Structural Heart Disease 2
Lead sponsor
John Sapp
Phase
Phase 4
Overall status
Completed
Start date
October 31, 2016
Completion date
June 30, 2024
Enrollment
416 (actual)
Sites
22

Conditions

As the registry lists them; a condition with its own page is linked.

ventricular tachycardia (vt)